After bringing in one of the top venture capital investments during first quarter 2015, Neos Therapeutics has filed for an initial public offering. The Grand Prairie-based company, which develops medication for Attention Deficit/Hyperactivity Disorder, filed Friday to trade on the Nasdaq under ticker symbol NEOS. It has a place holder value... (read more)